Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Settlement Agreement under which the company agreed to payments and separation benefits in connection with Mr. Race's resignation, including a one-time severance payment.
Consultancy Agreement under which Mr. Race will provide consulting services to the company at an hourly fee.
Consulting Agreement under which Dr. Kaul provides clinical trial and related services at an hourly rate.
Option grant to Dr. Kaul, a consultant option for 0.7% of the Share Total with staged vesting, plus top-up options.
Participation in the 2025 Private Placement of Series A Preferred Stock and warrants.
Support Agreements under which these stockholders agreed to vote their shares for specified proposals in connection with the 2025 Private Placement.
Purchase of 1,425,000 shares of Common Stock and pre-funded warrants for 575,575 shares in the 2023 Private Placement.
Right to designate a board observer until a Change of Control or until its holdings fall below 10% of Common Stock; observer designated August 29, 2023.
Loading...
